20th World Congress of Dermatology
?
Poster abstracts Thursday 4th July - Friday 5th July 2002 Psoriasis and related disorders P1929 Combination treatment is superior to single agent systemic therapy for safety in severe psoriasis P1930 Preparation "viusid" for treatment of dermal diseases P1931 Erythroderma: a review of 162 cases for the last five years P1932 Comparison of three vitamin D3 derivatives: tacalcitol 4mg/g, calcipotriol 50mg/g and calcitriol 3mg/g in the treatment of chronic plaque psoriasis P1933 Narrow band 311nm UV-light induces 12(s)-hydroxyeicosatetraenoic acid receptor down-regulation in psoriatic epidermal cells P1934 Similar efficacy and safety of clobetasol propionate as 0.05% lotion or cream in moderate to severe psoriasis P1935 A new formulation of clobetasol propionate is more effective and safer than 1% tar shampoo in scalp psoriasis P1936 Psoriasis: relationships between joint and skin disease P1937 Narrow-band ultraviolet B is a useful treatment for psoriasis P1938 An Interesting and Rare Case of Nail Involvement in Psoriasis P1939 Psoriasis of the scalp and alopecia P1940 Hepatobiliary system, radionuclear methods, bile acids and psoriasis P1941 Immune System and Bile acids metabolism in psoriatic patients P1942 Disaminoacidemia and bile acids metabolism in psoriatic patients P1943 Condition of cell immunity of patients that have psoriasis and vegetative nervous system disorders P1944 Ofuji's Papuloerythroderma: disease or pattern P1945 Efficacy and safety of infliximab in the treatment of severe plaque or arthropathic psoriasis: preliminary observations P1946 Evaluation of IL-6 and TNF-alfa in the sera of patients with Psoriasis P1947 Pathogenetic role of the putative keratin-17/interferon-gamma "autoimmune loop" in Psoriasis P1948 Psoriasis vulgaris as a diagnostic problem in a patient with myasthenia gravis. Case report P1949 Comparison of adhesion molecules ICAM-1, VCAM-1 and IL-2R in lesional and nonlesional skin of psoriatic patients with skin of healthy volunteers P1950 Patient's perception of psoriasis: survey based on a representative sample of the French population. III. Treatments and the doctor/patient relationship P1951 Psoriasis vulgaris induced by artificial ultraviolet (UV) exposure. Case report P1952 Patient perception of Psoriasis: a survey based on a representative sample of the French population. I. Demographic data and general concepts concerning the disease P1953 Photodynamic therapy in the treatment of plaque psoriasis: a new therapeutic approach P1954 Quality of life in patients with Psoriasis. A preliminary study from South India P1955 PUVA and tacalcitol in the initial treatment of Psoriasis vulgaris P1956 Plasma C1 levels of mycophenolic acid in the treatment of Psoriasis with mycophenolate P1957 Oral polypodium leucotomos extract minimizes the side effects UVB therapy for Psoriasis while preserving its effectiveness P1958 Psoriasis disability is related to length of history of Psoriasis P1959 The patients' perception of their Psoriasis and its treatment through a diary P1960 The war in Croatia like "trigger" in Psoriasis vulgaris P1961 Parapsoriasis variegata P1962 Palmo-plantar-lingual Psoriasis syndrome P1963 Role of lesional-skin and serum interleukin-1beta with immune t-cell activation in pathogenesis of Psoriasis P1964 Ocular anterior segment pathologies and tear-film changes in the patients with Psoriasis vulgaris P1965 Prevalence of enterotoxin producing Staphylococcus aureus among patients with psoriasis P1966 The coexistence of subacute cutaneous lupus erythematosus and psoriasis P1967 Psoriasis and everyday life: first results on 1,866 subjects P1968 The French version of the psoriasis disability index P1969 Evaluating solar radiation in psoriatic patients during climatotherapy in the Dead Sea area P1970 Alefacept improves psoriatic arthritis and reduces synovial inflammatory infiltrate P1971 Etanercept improves health-related quality of life in psoriatic arthritis patients P1972 Infliximab monotherapy normalizes keratinocyte differentiation & decreases inflammation in skin biopsies from patients with moderate to severe plaque psoriasis P1973 Infliximab prevents relapse of moderate to severe psoriasis in responding patients P1974 Response to pneumococcal vaccination in patients treated with etanercept P1975 Palmoplantar pustulosis: an autoimmune disease induced by smoking? P1976 Response to the calcipotriol (Daivonex) treatment in psoriasis patients P1977 Topical vitamin B12: potential for clinical use in psoriasis P1978 Immunolocalization of human beta defensin-2 (hBD-2) in psoriasis: alteration from cytoplasmic to intercellular expression in the epidermis P1979 Orthopeadic relations in treatment of sole hyperkeratosis P1980 Pustulotic arthro-osteitis and its complications P1981 Experimental K?bner phenomenon in patients with psoriasis P1982 Clinical efficacy of a unique 10% sulfacetamide lotion in patients with seborrheic dermatitis of the scalp P1983 A new calcipotriol/betamethasone formulation is a highly effective once-daily treatment for Psoriasis vulgaris P1984 Effects of topical 1a, 25-Dihydroxy-22-oxacalcitriol (maxacalcitol) on epidermal proliferation and differentiation in Psoriasis vulgaris P1985 Thalassotherapy of psoriasis patients in Bulgaria P1986 The long term use of razoxane for severe psoriasis P1987 Infliximab combination therapy for psoriasis P1988 Changes of pyruvate kinase activity and lactic acid concentration in polymorphonuclears depends on PASI in psoriatic patients P1989 Etanercept improves psoriasis in patients with psoriatic arthritis: results of a phase 3 multicenter clinical trial P1990 Tacrolimus ointment for the treatment of psoriasis on the face and intertriginous areas P1991 Alefacept provides long-lasting, durable remissions in patients with psoriasis P1992 Does balneotherapy improve PUVA treatment? P1993 Safety profile of alefacept: pooled results of placebo-controlled trials P1994 Short-contact tazarotene therapy for psoriasis P1995 Unresolving pityriasis rubra pilaris P1996 Ascorbic acid deficiency and iron overload in psoriatic dermis P1997 Psoriasis genomics: analysis of type 1 gene expression in large plaque and small plaque Psoriasis vulgaris P1998 Nail psoriasis successfully treated with fumaric acid ester P1999 Patient perception of psoriasis: a survey based on a representative sample of the French population. II. Embarrassment caused by psoriasis. Survey of the general population in France P2000 Psoriasis patients show improved quality of life when treated with etanercept P2001 Expression profiling of Psoriasis vulgaris using microarray technology P2002 HLA-CW*0602 in the pathogenesis of psoriasis P2003 Efficacy of infliximab in a patient with severe psoriasis P2004 K?bner: the same phenomenon in different diseases P2005 The PSORIQoL: a new tool for assessing quality of life in psoriasis P2006 Higher efficacy and safety of calcitriol 3mg/g ointment vs calcipotriol 50mg/g ointment on chronic plaque psoriasis of sensitive areas P2007 Efficacy of bettamousse on scalp psoriasis: the scale trial P2008 The adjuvant use of polypodium leucotomos extract (PLE) prevents the increase of CCR5 and CCR6 expression during UV therapy in psoriatic patients P2009 Peculiarities of clinical picture and course of psoriasis on the background of urogenital chlamydiosis P2010 Spectrophotometric intracutaneous analysis: a novel technique in the differential diagnosis of psoriasis and eczema P2011 Relationship between pharmacodynamic and clinical effects of alefacept in psoriasis P2012 Alefacept improves psoriasis and quality of life: results of a multiple-course trial P2013 Comparative study of effects balneotherapy itself and balneotherapy combined with topical medicaments on symptoms of Psoriasis vulgaris in Prolom Banj P2014 IgG response to recombinant 60kDa heat schock proteins in patients with psoriasis treated with cyclosporine, and its correlation with PASI P2015 HLA haplotypes associated with familial juvenile onset psoriasis in Croatian patients P2016 Long-term safety of cyclosporin (Cy-A) in the treatment of psoriasis: a 5 year cohort study P2017 Incidence of malignancy during oral cyclosporin (Cy-A) treatment of severe psoriasis P2018 Interleukin-18 levels in the sera of psoriatic patients: correlations with flow cytometry analysis P2019 Pruritus in psoriatic patients: correlation with disease activity P2020 The modern problems of diagnosis and treatement of psoriatic arthritis P2021 Psoriasis: the ring sign P2022 Appearance of Kaposi's sarcoma after methotrexate treatment P2023 HLA antigens in patients with psoriatic arthritis P2024 Infliximab treatment of psoriatic skin lesions P2025 Treatment of psoriasis in children with VIUSID and SKIN-CAP P2026 Abnormality in the organization of the stratum corneum lipids in psoriasis P2027 Psoriasis in Nepal: Clinical & epidemiological features in a hospital based study P2028 Clinical evaluation of a new psoriasis assessment severity score (PASS) and its comparison with the classic psoriasis area and severity index (PASI) P2029 Infliximab in the treatment of psoriatic arthritis and psoriasis P2030 Recurrent impetigo herpetiformis with hypoparathyroidism P2031 Remission of palmoplantar pustulosis after periodontal treatment: role of oral bacterial heat shock proteins P2032 Individual variations of treatment response with calcipotriol or/and betamethasone P2033 Decreased oxygen metabolism of neutrophils in psoriasis P2034 A guideline for treatment in generalized pustular psoriasis P2035 Familial cases of psoriasis vulgaris associated with uveitis P2036 Balneophototherapy in the treatment of psoriasis in clinical practice P2037 A fixed combination of calcipotriol/betamethasone dipropionate improves quality of life in patients with psoriasis vulgaris P2038 Association of C677T MTHFR gene polymorphism with psoriasis P2039 Neutrophilic cholangitis in patients with generalized pustular psoriasis: retrospective study in 20 patients P2040 The influence of naphthalan on epidermal proliferation activity and number of CD3, CD4 and CD8 lymphocytes P2041 Study on genetic epidemiology of psoriasis vulgaris in Han Chinese P2042 HLA-DQA1 and DQB1 alleles are associated with genetic susceptibility to psoriasis vulgaris in Han Chinese P2043 Tazarotene cream in the treatment of plaque psoriasis P2044 Ocular side effects in psoriatic patients after PUVA therapy P2045 Expression of nerve growth factor and keratinocyte growth factor in psoriasis and their clinical significance P2046 The Study of the Target Antigens of Basal Membrane Zone Antibodies in Lichen Planus Pemphigoid P2047 Evaluation of skin surface hydration in psoriasis patients P2048 Visual evoked potentials in patients with psoriasis vulgaris P2049 Serum levels of IgG subclasses in patients with psoriasis vulgaris during PUVA therapy P2050 HLA-C locus genotyping using PCR-SSP in patients with psoriasis vulgaris in Chinese Han population P2051 An immunohistological study of TGF-betas and their receptors in psoriatic lesions P2052 Searching for the susceptibility loci of psoriasis in Chinese patients P2053 Psoriasis in children in Latvia. A follow-up of 252 children under the age of 18 with psoriasis					1st TO 5th JULY 2002 PARIS Back to main menu Foreword Oral communications and co-opted speakers abstracts Poster abstracts Searching by Author's name Searching by Article's number

?